CytomX Therapeutics
CTMX
CTMX
114 hedge funds and large institutions have $275M invested in CytomX Therapeutics in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 36 increasing their positions, 45 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
41% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 17
96% less call options, than puts
Call options by funds: $9K | Put options by funds: $222K
Holders
114
Holding in Top 10
–
Calls
$9K
Puts
$222K
Top Buyers
| 1 | +$4.98M | |
| 2 | +$2.54M | |
| 3 | +$2.04M | |
| 4 |
ACM
Altium Capital Management
New York
|
+$1.89M |
| 5 |
Millennium Management
New York
|
+$1.73M |
Top Sellers
| 1 | -$10.4M | |
| 2 | -$4.87M | |
| 3 | -$3.6M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$2.95M |
| 5 |
Morgan Stanley
New York
|
-$2.63M |